Recent Interesting Articles from TCRN Members

In this monthly article the TCRN Operations & Projects team use on-line tools to identify publications attributed to TCRN members. We are using Scopus, the largest abstract and citation database of peer-reviewed literature as our primary source.

A “Scopus alert” has been created for any TCRN member who has been an author on a peer-reviewed publication. New results arrive weekly from Scopus, allowing us to create a database of all member publications for the year and then share some recent examples with the TCRN members each month.

Some examples of recent member publications can be seen below. Most university-based members will be able to go directly to the article using the links below. Unfortunately, hospital-based members may be blocked by firewalls and we are unable to find a fix for this problem. Any member who is interested in reading one of these papers but is unable to access them can email tcrn@unsw.edu.au and request a PDF copy.

Nic Giolla Easpaig B., Arnolda G., Tran Y., Bierbaum M., Lamprell K., Delaney G.P., Liauw W., Chittajallu R., Winata T., Ward R.L., Currow D.C., Olver I., Karnon J., Westbrook J., Braithwaite J. What is multidisciplinary cancer care like in practice? a protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector. BMJ Open (2019) DOI: 10.1136/bmjopen-2019-031179

Safi N., Anazodo A., Dickinson J.E., Lui K., Wang A.Y., Li Z., Sullivan E.A. In utero exposure to breast cancer treatment: a population-based perinatal outcome study. British Journal of Cancer (2019) DOI: 10.1038/s41416-019-0563-x

Hogden A., Churruca K., Rapport F., Gillatt D. Appraising risk in active surveillance of localized prostate cancer. Health Expectations (2019) DOI: 10.1111/hex.12912

Hardeman E.C., Bryce N.S., Gunning P.W. Impact of the actin cytoskeleton on cell development and function mediated via tropomyosin isoforms. Seminars in Cell and Developmental Biology (2019) DOI: 10.1016/j.semcdb.2019.10.004

Valle S.J., Akhter J., Mekkawy A.H., Lodh S., Pillai K., Badar S., Glenn D., Power M., Liauw W., Morris D.L. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study. European Journal of Surgical Oncology (2019) DOI: 10.1016/j.ejso.2019.10.033

Chambers S.K., Frydenberg M., Dunn J.  Quality of life considerations in the treatment of metastatic hormone-sensitive prostate cancer. The Lancet Oncology (2019) DOI: 10.1016/S1470-2045(19)30628-X

Werner B., Yuwono N.L., Henry C., Gunther K., Rapkins R.W., Ford C.E., Warton K. Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight. PLoS ONE (2019) DOI: 10.1371/journal.pone.0224338

Gerstl B., Sullivan E., Koch J., Wand H., Ives A., Mitchell R., Hamad N., Anazodo A. Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis. Supportive Care in Cancer (2019) DOI: 10.1007/s00520-019-05020-8

Schömel N., Hancock S.E., Gruber L., Olzomer E.M., Byrne F.L., Shah D., Hoehn K.L., Turner N., Grösch S., Geisslinger G., Wegner M.-S. UGCG influences glutamine metabolism of breast cancer cells. Scientific Reports (2019) DOI: 10.1038/s41598-019-52169-7

Tang M., Chen J., Goldstein D., Links M., Lord S., Marschner I., Simes R.J., Lee C.K. Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer. Pancreas (2019) DOI: 10.1097/MPA.0000000000001429

Tang M., Schaffer A., Kiely B.E., Daniels B., Simes R.J., Lee C.K., Pearson S.-A. Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016) British Journal of Cancer (2019) DOI: 10.1038/s41416-019-0612-5

Bryce N.S., Failes T.W., Stehn J.R., Baker K., Zahler S., Arzhaeva Y., Bischof L., Lyons C., Dedova I., Arndt G.M., Gaus K., Goult B.T., Hardeman E.C., Gunning P.W., Lock J.G. High-Content Imaging of Unbiased Chemical Perturbations Reveals that the Phenotypic Plasticity of the Actin Cytoskeleton Is Constrained. Cell Systems (2019) DOI: 10.1016/j.cels.2019.09.002

Friedlander M.L. Do all patients with recurrent ovarian cancer need systemic therapy? Cancer (2019) DOI: 10.1002/cncr.32476

Moles E., Kavallaris M. A potent targeted cancer nanotherapeutic. Nature Biomedical Engineering (2019) DOI: 10.1038/s41551-019-0390-7

Wang J., Ni J., Beretov J., Thompson J., Graham P., Li Y. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer. Critical Reviews in Oncology/Hematology (2020) DOI: 10.1016/j.critrevonc.2019.102860